Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$973.7M
-7.0% from 2023
Prescriptions
894K
$1,089.65 per claim
Patients
217K
87,949 prescribers
Total spending, 2024
$973.9M
$4,479.19 per patient
Medicare prescription drug plans paid $973.7M for Tresiba Flextouch U-200 in 2024, for 893,581 prescriptions and refills to 217,361 patients (down 7.0% from 2023). The average cost per claim was $1,089.65.
Texas had the highest Medicare cost for Tresiba Flextouch U-200 in 2024: $96.0M for 89,958 claims, followed by Florida ($65.1M).
Jaweed Akhter, endocrinology in Beaumont, TX, had the highest Medicare cost for Tresiba Flextouch U-200 in 2024: 726 claims costing $885K.
Tresiba Flextouch U-200 is made by Novo Nordisk A/S (NVO), listed in the Medicare spending data as Novo Nordisk.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jaweed Akhter Beaumont, TX | Endocrinology | 726 | 244 | $885K |
| Charla Yassine Wichita, KS | Certified Clinical Nurse Specialist | 429 | 108 | $659K |
| James A Dicke |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 77,856 | 825,171 | 186,113 | $1.00B |
| 2023 | 81,460 | 845,727 | 197,015 | $1.05B |
| 2024 | 87,949 | 893,581 | 217,361 | $973.7M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Endocrinology |
| 389 |
| 115 |
| $634K |
| Wendy Sanders Cedar Rapids, IA | Nurse Practitioner | 520 | 138 | $593K |
| Shahed Quyyumi Staten Island, NY | Endocrinology | 458 | 134 | $527K |
| Kelsey J Barr Pollocksville, NC | Endocrinology | 394 | 117 | $517K |
| Robert T Ferraro Albuquerque, NM | Endocrinology | 406 | 75 | $515K |
| Stacy Centeno Sarasota, FL | Nurse Practitioner | 367 | 118 | $514K |
| Gina L Bearden Knoxville, TN | Nurse Practitioner | 229 | 84 | $500K |
| Assem Houssein Lancaster, OH | Endocrinology | 286 | 75 | $494K |
| K. G Thampy Saint Louis, MO | Endocrinology | 293 | 88 | $486K |
| Ernest Asamoah Indianapolis, IN | Endocrinology | 312 | 85 | $483K |
| Susan K Murry Bryan, OH | Nurse Practitioner | 281 | 85 | $475K |
| Patrick Richards Sacramento, CA | Endocrinology | 408 | 113 | $473K |
| Arelis M Madera Port Charlotte, FL | Endocrinology | 354 | 125 | $462K |
| Nitika Malhotra Jacksonville, FL | Endocrinology | 414 | 109 | $440K |
| Sameer Ansar Rockford, IL | Endocrinology | 235 | 69 | $436K |
| Rae J Jessee Maysville, KY | Nurse Practitioner | 279 | 79 | $434K |
| Christopher C Case Jefferson City, MO | Endocrinology | 345 | 79 | $429K |
| Victor R Marlar Asheville, NC | Endocrinology | 368 | 94 | $428K |
| Ava C McPeake Jackson, TN | Nurse Practitioner | 380 | 115 | $427K |
| David J Domenichini Bloomfield, CT | Endocrinology | 249 | 77 | $425K |
| Ifeoma A Egbuonu El Paso, TX | Endocrinology | 266 | 98 | $420K |
| Vinay Kapoor Bayside, NY | Endocrinology | 388 | 110 | $414K |
| Marissa C Myres Peoria, IL | Certified Clinical Nurse Specialist | 204 | 68 | $405K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novo Nordisk NVO | 893,822 | $973.9M |